IL33 and systemic lupus erythematosus: For instance, interleukin-33 (IL-33), which has been the subject of study in rheumatological autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus (SLE), has demonstrated increased levels and roles in cytokine synthesis and the inflammatory response [20,23].